| Hypoxia and perfusion in breast cancer: simultaneous assessment using PET/MR imaging JC Carmona-Bozo, R Manavaki, R Woitek, T Torheim, GC Baxter, ... European Radiology 31, 333-344, 2021 | 39 | 2021 |
| Diffusion-weighted MRI for predicting pathologic complete response in neoadjuvant immunotherapy W Li, NN Le, N Onishi, DC Newitt, LJ Wilmes, JE Gibbs, J Carmona-Bozo, ... Cancers 14 (18), 4436, 2022 | 15 | 2022 |
| PET/MRI of hypoxia and vascular function in ER-positive breast cancer: correlations with immunohistochemistry JC Carmona-Bozo, R Manavaki, JL Miller, C Brodie, C Caracò, R Woitek, ... European Radiology 33 (9), 6168-6178, 2023 | 3 | 2023 |
| Abstract pd16-06: Early mri and pet biomarkers for hormone receptor-positive/her2-negative early-stage breast cancer in the setting of neoadjuvant endocrine therapy and … N Onishi, EF Jones, J Carmona-Bozo, JE Gibbs, TJ Bareng, ... Cancer Research 83 (5_Supplement), PD16-06-PD16-06, 2023 | 2 | 2023 |
| Post-Processing Bias Field Inhomogeneity Correction for Assessing Background Parenchymal Enhancement on Breast MRI as a Quantitative Marker of Treatment Response AAT Nguyen, N Onishi, J Carmona-Bozo, W Li, J Kornak, DC Newitt, ... Tomography 8 (2), 891-904, 2022 | 2 | 2022 |
| Abstract P6-01-33: Diffusion-weighted magnetic resonance imaging for subtype-specific prediction of pathologic complete response in neoadjuvant chemotherapy J Zimmermann, J Carmona-Bozo, NN Le, N Onishi, LJ Wilmes, JE Gibbs, ... Cancer Research 83 (5_Supplement), P6-01-33-P6-01-33, 2023 | 1 | 2023 |
| Post-Processing Bias Field Inhomogeneity Correction for Assessing Background Parenchymal Enhancement on Breast MRI as a Quantitative Marker of Treatment Response. Tomography … AA Nguyen, N Onishi, J Carmona-Bozo, W Li, J Kornak, DC Newitt, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | 1 | 2022 |
| Quantifying the tumour vasculature environment from CD-31 immunohistochemistry images of breast cancer using deep learning based semantic segmentation T Whitmarsh, W Cope, J Carmona-Bozo, R Manavaki, SJ Sammut, ... Breast Cancer Research: BCR 27, 17, 2025 | | 2025 |
| PET/MRI of hypoxia in ER plus breast cancer: Correlations with immunohistochemistry J Carmona-Bozo, R Manavaki, J Miller, C Brodie, C Caraco, G Baxter, ... EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 49 (SUPPL 1 …, 2022 | | 2022 |
| PET-MR imaging of hypoxia and vascularity in breast cancer JC Carmona-Bozo | | 2021 |
| Can the number of tumour feeding vessels predict hypoxia in breast cancer? A study using combined F-18-FMISO PET-MRI J Carmona-Bozo, R Manavaki, G Baxter, R Woitek, A Patterson, ... EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 46 (SUPPL 1 …, 2019 | | 2019 |
| Hypoxia in ER plus breast cancer: a study using combined PET/MR imaging J Carmona-Bozo, R Manavaki, A Patterson, R Woitek, T Torheim, ... BREAST CANCER RESEARCH 19, 2017 | | 2017 |
| Predicting response to neoadjuvant chemotherapy in breast cancer: machine learning-based analysis of radiomics features from baseline DCE-MRI G Baxter, AJ Patterson, L Rundo, R Woitek, R Bedair, J Carmona-Bozo, ... | | |
